Subthreshold α2 -adrenergic activation counteracts glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion

Experimental Diabetes Research

Volumn 2011, Issue , 2011, Pages

  Yang, Shao Nian ^a   Pan, Minglin ^a   Yang, Guang ^a   Cui, Xiuli ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; NORADRENALIN; ENZYME INHIBITOR; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; PERTUSSIS TOXIN; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE HOMEOSTASIS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; HYPERGLYCEMIA; METABOLISM; OSMOLARITY; SECRETION;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; CELL LINE; CLONIDINE; ENZYME INHIBITORS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; LIGANDS; OSMOLAR CONCENTRATION; PERTUSSIS TOXIN; PROTEIN SUBUNITS; RATS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 79952263671     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2011/604989     Document Type: Article

References (39)

1. Yang S. N., Berggren P. O., -cell CaV channel regulation in physiology and pathophysiology American journal of physiology. Endocrinology and metabolism 2005 288 1 E16 E28
2. Yang S. N., Berggren P. O., Ca V 2.3 channel and PKC : new players in insulin secretion Journal of Clinical Investigation 2005 115 1 16 20
3. Yang S. N., Berggren P. O., The role of voltage-gated calcium channels in pancreatic -cell physiology and pathophysiology Endocrine Reviews 2006 27 6 621 676
4. Sharp G. W., Mechanisms of inhibition of insulin release American Journal of Physiology 1996 271 6 C1781 C1799
5. Ahrn B., Autonomic regulation of islet hormone secretionimplications for health and disease Diabetologia 2000 43 4 393 410
6. Gilon P., Henquin J. C., Mechanisms and physiological significance o (Pubitemid 32958576)
7. Nilsson T., Arkhammar P., Rorsman P., Berggren P. O., Inhibition of glucose-stimulated insulin release by 2 -adrenoceptor activation is parallelled by both a repolarization and a reduction in cytoplasmic free Ca2+ concentration Journal of Biological Chemistry 1988 263 4 1855 1860 (Pubitemid 18052140)
8. Langer J., Panten U., Zielmann S., Effects of -adrenoceptor antagonists on clonidine-induced inhibition of insulin secretion by isolated pancreatic islets British Journal of Pharmacology 1983 79 2 415 420 (Pubitemid 13055409)
9. Holst J. J., The physiology of glucagon-like peptide 1 Physiological Reviews 2007 87 4 1409 1439 (Pubitemid 350041474)
10. Kieffer T. J., Habener J. F., The glucagon-like peptides Endocrine Reviews 1999 20 6 876 913 (Pubitemid 30647076)
11. Kim W., Egan J. M., The role of incretins in glucose homeostasis and diabetes treatment Pharmacological Reviews 2008 60 4 470 512
12. Gromada J., Brock B., Schmitz O., Rorsman P., Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential Basic Clinical Pharmacology Toxicology 2004 95 6 252 262 (Pubitemid 39657642)
13. Hauge-Evans A. C., King A. J., Carmignac D., Richardson C. C., Robinson I. C. A. F., Low M. J., Christie M. R., Persaud S. J., Jones P. M., Somatostatin secreted by islet -cells fulfills multipleRoles as a paracrine regulator of islet function Diabetes 2009 58 2 403 411
14. Moens K., Berger V., Ahn J. M., Van Schravendijk C., Hruby V. J., Pipeleers D., Schuit F., Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic -cells Diabetes 2002 51 3 669 675 (Pubitemid 34760174)
15. Ueno N., Inui A., Asakawa A., Yuzuriha H., Kasuga M., Fujimiya M., Impaired glucose tolerance in pancreatic polypeptide-overexpressing mice Diabetologia 2002 45 7 1048 1049 (Pubitemid 34762205)
16. Reimer M. K., Pacini G., Ahrn B., Dose-dependent inhibition by ghrelin of insulin secretion in the mouse Endocrinology 2003 144 3 916 921 (Pubitemid 36262858)
17. Jacques-Silva M. C., Correa-Medina M., Cabrera O., Rodriguez-Diaz R., Makeeva N., Fachado A., Diez J., Berman D. M., Kenyon N. S., Ricordi C., Pileggi A., Molano R. D., Berggren P. O., Caicedo A., ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic cell Proceedings of the National Academy of Sciences of the United States of America 2010 107 14 6465 6470
18. Ferrer R., Soria B., Dawson C. M., Atwater I., Rojas E., Effects of Zn2+ on glucose-induced electrical activity and insulin release from mouse pancreatic islets American Journal of Physiology 1984 246 5 C520 C527
19. Lambillotte C., Gilon P., Henquin J. C., Direct glucocorticoid inhibition of insulin secretion: an in vitro study of dexamethasone effects in mouse islets Journal of Clinical Investigation 1997 99 3 414 423 (Pubitemid 27414798)
20. Gromada J., Bokvist K., Ding W. G., Holst J. J., Nielsen J. H., Rorsman P., Glucagon-like peptide 1(736) amide stimulates exocytosis in human pancreatic -cells by both proximal and distal regulatory steps in stimulus-secretion coupling Diabetes 1998 47 1 57 65 (Pubitemid 28030808)
21. Gromada J., Holst J. J., Rorsman P., Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1 Pflugers Archiv European Journal of Physiology 1998 435 5 583 594 (Pubitemid 28098639)
22. Gromada J., Ding W. G., Barg S., Renstrm E., Rorsman P., Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors Pflugers Archiv European Journal of Physiology 1997 434 5 515 524 (Pubitemid 27355170)
23. Yang S. N., Larsson O., Brnstrm R., Bertorello A. M., Leibiger B., Leibiger I. B., Moede T., Khler M., Meister B., Berggren P. O., Syntaxin 1 interacts with the LD subtype of voltage-gated Ca2+ channels in pancreatic cells Proceedings of the National Academy of Sciences of the United States of America 1999 96 18 10164 10169 (Pubitemid 29422530)
24. Yu J., Berggren P. O., Barker C. J., An autocrine insulin feedback loop maintains pancreatic -cell 3-phosphorylated inositol lipids Molecular Endocrinology 2007 21 11 2775 2784 (Pubitemid 350035158)
25. Ullrich S., Wollheim C. B., Islet cyclic AMP levels are not lowered during 2 -adrenergic inhibition of insulin release Journal of Biological Chemistry 1984 259 7 4111 4115
26. Shigeto M., Katsura M., Matsuda M., Ohkuma S., Kaku K., Low, but physiological, concentration of GLP-1 stimulates insulin secretion independent of the cAMP-dependent protein kinase pathway Journal of Pharmacological Sciences 2008 108 3 274 279
27. Fuxe K., Marcellino D., Guidolin D., Woods A. S., Agnati L. F., Heterodimers and receptor mosaics of different types of G-protein-coupled receptors Physiology 2008 23 6 322 332
28. Fuxe K., Marcellino D., Leo G., Agnati L. F., Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis Current Opinion in Pharmacology 2010 10 1 14 22
29. Agnati L. F., Fuxe K., Zini I., Lenzi P., Hkfelt T., Aspects on receptor regulation and isoreceptor identification Medical Biology 1980 58 4 182 187 (Pubitemid 11164423)
30. Agnati L. F., Fuxe K., Zoli M., Rondanini C., Ogren S. O., New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram Medical Biology 1982 60 4 183 190 (Pubitemid 13253962)
31. Werry T. D., Wilkinson G. F., Willars G. B., Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+ Biochemical Journal 2003 374 2 281 296 (Pubitemid 37094087)
32. Yang S. N., Fior D. R., Hansson A. C., Cintra A., Castellano M., Ganten U., Ganten D., Agnati L. F., Fuxe K., Increased potency of neuropeptide Y to antagonize 2 -adrenoceptor function in the nucleus tractus solitarii of the spontaneously hypertensive rat Neuroscience 1997 78 3 803 813 (Pubitemid 27179660)
33. Yang S. N., Dasgupta S., Lledo P. M., Vincent J. D., Fuxe K., Reduction of dopamine D2 receptor transduction by activation of adenosine A2a receptors in stably A2a / D2 (long-form) receptor co-transfected mouse fibroblast cell lines: studies on intracellular calcium levels Neuroscience 1995 68 3 729 736
34. Malpas S. C., Sympathetic nervous system overactivity and its role in the development of cardiovascular disease Physiological Reviews 2010 90 2 513 557
35. Carlson S. H., Shelton J., White C. R., Wyss J. M., Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats Hypertension 2000 35 1 403 408 (Pubitemid 30054207)
36. Greenfield J. R., Campbell L. V., Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: targets for therapy? Current Pharmaceutical Design 2008 14 18 1815 1820 (Pubitemid 351998585)
37. Rosengren A. H., Jokubka R., Tojjar D., Granhall C., Hansson O., Li D. Q., Nagaraj V., Reinbothe T. M., Tuncel J., Eliasson L., Groop L., Rorsman P., Salehi A., Lyssenko V., Luthman H., Renstrm E., Overexpression of 2A -adrenergic receptors contributes to type 2 diabetes Science 2010 327 5962 217 220
38. Gribble F. M., 2 A -adrenergic receptors and type 2 diabetes The New England Journal of Medicine 2010 362 4 361 362
39. Lambert G. W., Straznicky N. E., Lambert E. A., Dixon J. B., Schlaich M. P., Sympathetic nervous activation in obesity and the metabolic syndromecauses, consequences and therapeutic implications Pharmacology and Therapeutics 2010 126 2 159 172